{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"familial-partial-lipodystrophy","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"Familial partial lipodystrophy is a rare condition characterized by an abnormal distribution of fatty (adipose) tissue. Adipose tissue is normally found in many parts of the body, including beneath the skin and surrounding the internal organs. It stores fat as a source of energy and also provides cushioning. In people with familial partial lipodystrophy, adipose tissue is lost from the arms, legs, and hips, giving these parts of the body a very muscular appearance. The fat that cannot be stored in the limbs builds up around the face and neck, and inside the abdomen. Excess fat in these areas gives individuals an appearance described as &quot;cushingoid,&quot; because it resembles the physical features associated with a hormonal disorder called Cushing disease. This abnormal fat distribution can begin anytime from childhood to adulthood.","mondoId":"MONDO:0020088","node":{"canonicalSlug":"familial-partial-lipodystrophy","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":["Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in several different genes cause familial partial lipodystrophy. Pathogenic variants in the lamin A/C (LMNA) gene cause familial partial lipodystrophy type 2. The other forms of the disorder are caused by pathogenic variants in other genes.","The LMNA gene provides instructions for making proteins called lamins, which are an important part of the structure that surrounds the nucleus inside cells (the nuclear envelope). Through a mechanism that is not well understood, pathogenic variants in the LMNA gene appear to lead to the premature death of adipocytes, which are the fat-storing cells in adipose tissue. The loss of these cells disrupts the body’s ability to store and use fats properly. This leads to the abnormal distribution of adipose tissue and the resulting health complications that are characteristic of this disorder. Changes in adipose tissue alter hormone production and affect many of the body's organs. However, it is unclear exactly why these changes cause fat to be lost in some parts of the body and abnormally stored in others.","The other genes that are associated with familial partial lipodystrophy provide instructions for making proteins with important roles in fat storage. Specifically, these proteins are necessary for the proper development and function of adipocytes. Pathogenic variants in any of the genes that are associated with familial partial lipodystrophy impair the development, structure, or function of adipocytes and make the body unable to store and use fats properly.","In some people with familial partial lipodystrophy, a pathogenic variant cannot be identified. In these cases, the cause of the disorder is unknown."],"causesUrl":"https://medlineplus.gov/genetics/condition/familial-partial-lipodystrophy/#causes","contentForm":"summary","matchMethod":"automatic-preferred-name","name":"Familial partial lipodystrophy","paragraphs":["Familial partial lipodystrophy is a rare condition characterized by an abnormal distribution of fatty (adipose) tissue. Adipose tissue is normally found in many parts of the body, including beneath the skin and surrounding the internal organs. It stores fat as a source of energy and also provides cushioning. In people with familial partial lipodystrophy, adipose tissue is lost from the arms, legs, and hips, giving these parts of the body a very muscular appearance. The fat that cannot be stored in the limbs builds up around the face and neck, and inside the abdomen. Excess fat in these areas gives individuals an appearance described as \"cushingoid,\" because it resembles the physical features associated with a hormonal disorder called Cushing disease. This abnormal fat distribution can begin anytime from childhood to adulthood.","Abnormal storage of fat in the body can lead to health problems in adulthood. Many people with familial partial lipodystrophy develop insulin resistance, a condition in which the body's tissues cannot adequately respond to insulin, which is a hormone that normally helps to regulate blood sugar (glucose) levels. Insulin resistance may worsen to become a more serious disease called diabetes mellitus. Some people with familial partial lipodystrophy develop acanthosis nigricans, a skin condition related to high levels of insulin in the bloodstream. Acanthosis nigricans causes the skin in body folds and creases to become thick, dark, and velvety.","Most people with familial partial lipodystrophy also have high levels of fats called triglycerides circulating in the bloodstream (hypertriglyceridemia), which can lead to inflammation of the pancreas (pancreatitis). Familial partial lipodystrophy can also cause an abnormal buildup of fats in the liver (hepatic steatosis), which can result in an enlarged liver (hepatomegaly) and abnormal liver function. After puberty, some affected females develop multiple cysts on the ovaries, an increased amount of body hair (hirsutism), and an inability to conceive (infertility), which are likely related to hormonal changes.","Researchers have described at least six forms of familial partial lipodystrophy, which are distinguished by their genetic cause. The most common form of familial partial lipodystrophy is type 2, also called Dunnigan disease. In addition to the signs and symptoms described above, some people with this type of the disorder develop muscle weakness (myopathy), abnormalities of the heart muscle (cardiomyopathy), a form of heart disease called coronary artery disease, and problems with the electrical system that coordinates the heartbeat (the conduction system)."],"reviewed":"2016-09","scope":"exact","scopeNote":"","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/familial-partial-lipodystrophy"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"hereditary lipodystrophy","mondoId":"MONDO:0020087","slug":"hereditary-lipodystrophy"},{"kind":"parent","label":"laminopathy","mondoId":"MONDO:0021106","slug":"laminopathy"},{"kind":"parent","label":"partial lipodystrophy","mondoId":"MONDO:0027767","slug":"partial-lipodystrophy"},{"kind":"child","label":"familial partial lipodystrophy, Dunnigan type","mondoId":"MONDO:0007906","slug":"familial-partial-lipodystrophy-dunnigan-type"},{"kind":"child","label":"PPARG-related familial partial lipodystrophy","mondoId":"MONDO:0011448","slug":"pparg-related-familial-partial-lipodystrophy"},{"kind":"child","label":"partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome","mondoId":"MONDO:0011714","slug":"partial-lipodystrophy-congenital-cataracts-and-neurodegeneration"},{"kind":"child","label":"familial partial lipodystrophy, Kobberling type","mondoId":"MONDO:0012072","slug":"familial-partial-lipodystrophy-kobberling-type"},{"kind":"child","label":"PLIN1-related familial partial lipodystrophy","mondoId":"MONDO:0013478","slug":"plin1-related-familial-partial-lipodystrophy"},{"kind":"child","label":"CIDEC-related familial partial lipodystrophy","mondoId":"MONDO:0014098","slug":"cidec-related-familial-partial-lipodystrophy"},{"kind":"child","label":"LIPE-related familial partial lipodystrophy","mondoId":"MONDO:0014431","slug":"lipe-related-familial-partial-lipodystrophy"},{"kind":"child","label":"autosomal semi-dominant severe lipodystrophic laminopathy","mondoId":"MONDO:0017230","slug":"autosomal-semi-dominant-severe-lipodystrophic-laminopathy"},{"kind":"child","label":"AKT2-related familial partial lipodystrophy","mondoId":"MONDO:0019192","slug":"akt2-related-familial-partial-lipodystrophy"},{"kind":"child","label":"lipodystrophy, familial partial, type 8","mondoId":"MONDO:0958022","slug":"lipodystrophy-familial-partial-type-8"},{"kind":"child","label":"lipodystrophy, familial partial, type 9","mondoId":"MONDO:0958034","slug":"lipodystrophy-familial-partial-type-9"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/11962","pageMondoId":"MONDO:0020088","source":"GARD","name":"Familial partial lipodystrophy","url":"https://rarediseases.info.nih.gov/diseases/11962","relationToPage":"same-condition","coveredMondoIds":["MONDO:0020088"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-21T15:49:15Z","upstream":"GARD:0011962","rawAttribution":"MONDO:0020088","independentCorroborationEstablished":false}]},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/familial-partial-lipodystrophy\" rel=\"noreferrer\">MedlinePlus</a></p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/11962\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0020088\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>automatic-preferred-name</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Familial partial lipodystrophy is a rare condition characterized by an abnormal distribution of fatty (adipose) tissue. Adipose tissue is normally found in many parts of the body, including beneath the skin and surrounding the internal organs. It stores fat as a source of energy and also provides cushioning. In people with familial partial lipodystrophy, adipose tissue is lost from the arms, legs, and hips, giving these parts of the body a very muscular appearance. The fat that cannot be stored in the limbs builds up around the face and neck, and inside the abdomen. Excess fat in these areas gives individuals an appearance described as &quot;cushingoid,&quot; because it resembles the physical features associated with a hormonal disorder called Cushing disease. This abnormal fat distribution can begin anytime from childhood to adulthood.</p><p>Abnormal storage of fat in the body can lead to health problems in adulthood. Many people with familial partial lipodystrophy develop insulin resistance, a condition in which the body&#x27;s tissues cannot adequately respond to insulin, which is a hormone that normally helps to regulate blood sugar (glucose) levels. Insulin resistance may worsen to become a more serious disease called diabetes mellitus. Some people with familial partial lipodystrophy develop acanthosis nigricans, a skin condition related to high levels of insulin in the bloodstream. Acanthosis nigricans causes the skin in body folds and creases to become thick, dark, and velvety.</p><p>Most people with familial partial lipodystrophy also have high levels of fats called triglycerides circulating in the bloodstream (hypertriglyceridemia), which can lead to inflammation of the pancreas (pancreatitis). Familial partial lipodystrophy can also cause an abnormal buildup of fats in the liver (hepatic steatosis), which can result in an enlarged liver (hepatomegaly) and abnormal liver function. After puberty, some affected females develop multiple cysts on the ovaries, an increased amount of body hair (hirsutism), and an inability to conceive (infertility), which are likely related to hormonal changes.</p><p>Researchers have described at least six forms of familial partial lipodystrophy, which are distinguished by their genetic cause. The most common form of familial partial lipodystrophy is type 2, also called Dunnigan disease. In addition to the signs and symptoms described above, some people with this type of the disorder develop muscle weakness (myopathy), abnormalities of the heart muscle (cardiomyopathy), a form of heart disease called coronary artery disease, and problems with the electrical system that coordinates the heartbeat (the conduction system).</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/familial-partial-lipodystrophy\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Genetic changes that cause disease are called pathogenic variants. Pathogenic variants in several different genes cause familial partial lipodystrophy. Pathogenic variants in the lamin A/C (LMNA) gene cause familial partial lipodystrophy type 2. The other forms of the disorder are caused by pathogenic variants in other genes.</p><p>The LMNA gene provides instructions for making proteins called lamins, which are an important part of the structure that surrounds the nucleus inside cells (the nuclear envelope). Through a mechanism that is not well understood, pathogenic variants in the LMNA gene appear to lead to the premature death of adipocytes, which are the fat-storing cells in adipose tissue. The loss of these cells disrupts the body’s ability to store and use fats properly. This leads to the abnormal distribution of adipose tissue and the resulting health complications that are characteristic of this disorder. Changes in adipose tissue alter hormone production and affect many of the body&#x27;s organs. However, it is unclear exactly why these changes cause fat to be lost in some parts of the body and abnormally stored in others.</p><p>The other genes that are associated with familial partial lipodystrophy provide instructions for making proteins with important roles in fat storage. Specifically, these proteins are necessary for the proper development and function of adipocytes. Pathogenic variants in any of the genes that are associated with familial partial lipodystrophy impair the development, structure, or function of adipocytes and make the body unable to store and use fats properly.</p><p>In some people with familial partial lipodystrophy, a pathogenic variant cannot be identified. In these cases, the cause of the disorder is unknown.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/familial-partial-lipodystrophy/#causes\" rel=\"noreferrer\">MedlinePlus</a></p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"familial-partial-lipodystrophy","sourceDocuments":[{"name":"MedlinePlus: Familial partial lipodystrophy","reviewed":"2016-09","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/familial-partial-lipodystrophy"},{"name":"GARD: Familial partial lipodystrophy","reviewed":null,"source_release":"2026-10-21T15:49:15Z","url":"https://rarediseases.info.nih.gov/diseases/11962"},{"name":"MONDO: familial partial lipodystrophy","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0020088"}],"sourceNote":"","synonyms":["congenital partial lipodystrophy","FPLD","genetic partial lipodystrophy","lipodystrophy, familial partial"],"takeawayHtml":"","title":"familial partial lipodystrophy"},"schemaVersion":1}
